EPSTEIN-BARR VIRUS INFECTION
Clinical trials for EPSTEIN-BARR VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN-BARR VIRUS INFECTION trials appear
Sign up with your email to follow new studies for EPSTEIN-BARR VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a nanoparticle vaccine stop the virus behind mono and some cancers?
⭐️ VACCINE ⭐️ CompletedThis early-stage trial is testing whether a new vaccine can safely train the immune system to fight Epstein-Barr virus (EBV), which causes infectious mononucleosis and is linked to several cancers. Healthy adults aged 18 to 29, both with and without prior EBV infection, will rece…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Aug 15, 2026 00:00 UTC
-
Could a vaccine finally stop the 'Kissing Disease'?
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes most cases of infectious mononucleosis (mono). Twenty-five healthy adults aged 18 to 25 who had never been infected with EBV received either the vaccine or a placebo. The goal was…
Matched conditions: EPSTEIN-BARR VIRUS INFECTION
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC